AI Eye Podcast 565: Stocks discussed: (OTCPINK: $GTCH) (NasdaqGS: $SRGA)

Point Roberts, WA and Vancouver, BC – June 7, 2021 ( Newswire) (, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye – watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Listen to today’s podcast:

AI Eye Podcast 565: Stocks discussed: (OTCPINK: $GTCH) (NasdaqGS: $SRGA)


Hear the AI Eye on Spotify

Today’s ColumnThe AI Eye – Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTCPINK:GTCH) (NasdaqGS:SRGA)

GBT Technologies Inc. (OTC PINK:GTCH) has announced that it has commenced research on the development of an AI-empowered, wireless patient monitoring system with the internal code name Apollo. GBT’s CTO Danny Rittman explained:

“We are researching to develop an out-of-the-box monitoring device for patients and the elderly that is radio-based and AI-empowered. It is our goal to particularly serve people that do not like to wear monitoring devices and yet need to be monitored at their home or at a facility. The Apollo device will be using RF signals to transmit in specific frequencies and analyze the reflection data. It is our goal to use a deep learning analysis to determine if the data belong to a human or objects and will calculate heart rate, breathing, and movement. It is our goal that a person would not need to wear any electronic device and the system will be able to detect his/her daily activities. The goal of the system will be to detect, in real time, irregularities like a fall, low breathing or an irregular heartbeat and to alert emergency response. Since the system will be working via radio waves, it will be able to cover an entire home environment.”

Medical tech firm Surgalign Holdings, Inc. (NasdaqGS:SRGA) has entered into a strategic collaboration agreement with Inteneural Networks Inc., the latter of which is described as “a developer of innovative artificial intelligence (AI) based applications focused on fully autonomous analytics of central nervous system imaging.” The collaboration will see Surgalign “gain access to Inteneural’s proprietary technology for evaluation of future integration within the Surgalign digital surgery portfolio.” Surgalign’s CEO Terry Rich said:

“While our initial focus is the application of digital surgery in spine procedures, we have a much more expansive vision for what we believe is possible with emerging technologies. New developments in the application of AI in neurosurgery and medical imaging make it an attractive space to further expand. Inteneural has developed machine learning-based analytics and fully autonomous brain anatomy segmentation capabilities that would be incredibly powerful when combined with neurosurgery. The agreement between Surgalign and Inteneural sets the foundation for potentially enhanced research and development efficiencies, expansion of the addressable markets, and acceleration of the technological progress in the digital surgery space generally.”

Global AI in Healthcare Diagnosis Market to Reach $66.81B by 2027

A report published by Research and Markets finds that the global AI in Healthcare Diagnosis market will grow from $3.63 billion in 2019 to $66.81 billion by 2027 with a compound annual growth rate (CAGR) of 43.8 percent in the forecast period. The following excerpt from the report’s description outlines the influence of startups on the market’s growth:

Artificial Intelligence in healthcare is one of the most significant technological advancements in medicine so far. The involvement of multiple startups in the development of AI-driven imaging and diagnostic solutions is the major factor contributing to the growth of the market. China, the US, and the UK are emerging as popular hubs for healthcare innovations. Additionally, the British government has announced the establishment of a National Artificial Intelligence Lab that would collaborate with the country’s universities and technology companies to conduct research on cancer, dementia, and heart diseases. The UK-based startups have received benefits from the government’s robust library of patient data, as British citizens share their anonymous healthcare data with the British National Health Service. As a result, the number of artificial intelligence startups in the healthcare sector has significantly grown in the past few years, and the trend is expected to be the same in the coming years.

Sam Mowers,

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on visit here or become an Investor Ideas member

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

About – News that Inspires Big Investing Ideas publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns: Crypto Corner, Play by Play sports and stock news, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast, Cleantech and Climate Change, Exploring Mining, Betting on Gaming Stocks Podcast and the AI Eye Podcast.

The podcasts are also available on iTunes (Apple Podcasts), Audible , Spotify, Tunein, Stitcher,, iHeartRadio, Google Play Music and most audio platforms available.

Visit the Podcast page at

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and Global investors must adhere to regulations of each country. Please read privacy policy:

Disclosure: GTCH is a paid monthly featured ai stock

The AI Eye – Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of

Follow us on Twitter

Follow us on Facebook

Follow us on YouTube

Download our Mobile App for iPhone and Android


800 665 0411

Buy a technology guest post on

What's your reaction?

In Love
Not Sure

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News